Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules

Carlo Fabris, Edmondo Falleti, Mario Pirisi, Giorgio Soardo, Pierluigi Toniutto, Daniela Vitulli, Nadia Bortolotti, Fabio Gonano, Ettore Bartoli

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Sialyl-Lewisa antigen (SLea), the immune determinant of carbohydrate antigen 19-9 (CA 19-9), is the ligand of E-selectin. To verify the possibility of an association between non-specific elevation of CA 19-9 and adhesion molecules, sera from 12 patients with acute hepatitis, 55 with non-cirrhotic chronic liver disease, 33 with cirrhosis and 25 with hepatocellular carcinoma, were tested for common liver function tests. Besides, CA 19-9 and soluble forms of E-selectin, VCAM-1 and ICAM-1 were measured immunoenzymatically. One-way analysis of variance demonstrated that mean CA 19-9 concentration differed among groups (F 15.27, P < 0.0001) with the highest values found in patients with acute hepatitis. By univariate analysis, the strongest correlation of CA 19-9 was with soluble ICAM-1, which by stepwise multiple regression analysis was the only independent predictor of elevated CA 19-9 (multiple R 0.560). The association between ICAM-1 and CA 19-9 might originate in the biliary cells where they might be simultaneously overexpressed during inflammatory processes.

Lingua originaleInglese
pagine (da-a)25-33
Numero di pagine9
RivistaClinica Chimica Acta
Volume243
Numero di pubblicazione1
DOI
Stato di pubblicazionePubblicato - 15 dic 1995
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules'. Insieme formano una fingerprint unica.

Cita questo